Stanley C. Erck
2018
In 2018, Stanley C. Erck earned a total compensation of $4.2M as President and CEO at Novavax, a 50% increase compared to previous year.
Compensation breakdown
| Option Awards | $3,509,358 |
|---|---|
| Salary | $638,040 |
| Other | $11,000 |
| Total | $4,158,398 |
Erck received $3.5M in option awards, accounting for 84% of the total pay in 2018.
Erck also received $638K in salary and $11K in other compensation.
Rankings
In 2018, Stanley C. Erck's compensation ranked 2,643rd out of 14,244 executives tracked by ExecPay. In other words, Erck earned more than 81.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,643 out of 14,244 | 81st |
Division Manufacturing | 981 out of 5,758 | 83rd |
Major group Chemicals And Allied Products | 335 out of 2,119 | 84th |
Industry group Drugs | 273 out of 1,808 | 85th |
Industry Biological Products, Except Diagnostic Substances | 56 out of 339 | 84th |
Pay ratio
| Stanley C. Erck's Pay | $4,158,398 |
|---|---|
| Median Employee's Pay | $123,614 |
| Pay Ratio | 34to 1 |
In 2018, the annual total compensation of Stanley C. Erck was $4,158,398.
The annual total compensation of the median employee at Novavax was $123,614.
The ratio of Stanley C. Erck's pay to the pay of median employee was therefore 34 to one.
Source: SEC filing on May 16, 2019.
Erck's colleagues
We found three more compensation records of executives who worked with Stanley C. Erck at Novavax in 2018.